# Dr Reddy's Laboratories Ltd (DRREDDY)

NSE equity · series EQ · Pharmaceuticals · Large Cap

Data as of **2026-10-01**. End-of-day data derived from NSE bhavcopy. Historical prices are adjusted for splits and bonuses.

## Latest session

| Field | Value |
| --- | --- |
| Close | ₹1,206.2 |
| Change | -26.8 (-2.17%) |
| Open / High / Low | 1,233 / 1,233.9 / 1,194.9 |
| Volume | 26,07,818 |
| Delivery | 65.2% |
| VWAP | 1,212.16 |
| 52-week high / low | 1,375.7 / 1,135.6 |
| From 52-week high | -12.32% |
| Market cap | ₹1,02,872.13 crore |

## Returns

| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD |
| --- | --- | --- | --- | --- | --- | --- | --- |
| +0.48% | +3.01% | -9.98% | -0.28% | -3.09% | +13392.17% | +15110.59% | -5.13% |

## Last 10 sessions

| Date | Open | High | Low | Close | Volume | Delivery % |
| --- | --- | --- | --- | --- | --- | --- |
| 2026-10-01 | 1,233 | 1,233.9 | 1,194.9 | 1,206.2 | 26,07,818 | 65.2 |
| 2026-09-30 | 1,242.2 | 1,244.6 | 1,214.2 | 1,233 | 40,26,022 | 60.08 |
| 2026-09-29 | 1,243.2 | 1,252.8 | 1,229 | 1,251.9 | 53,47,128 | 45.84 |
| 2026-09-28 | 1,211.6 | 1,229.8 | 1,204 | 1,221 | 34,01,676 | 49.95 |
| 2026-09-25 | 1,204.5 | 1,207.8 | 1,193.4 | 1,201 | 10,01,238 | 61.1 |
| 2026-09-24 | 1,210.9 | 1,213.9 | 1,197 | 1,200.4 | 16,67,696 | 65.03 |
| 2026-09-23 | 1,210 | 1,220.5 | 1,205.9 | 1,211.2 | 9,87,420 | 62.24 |
| 2026-09-22 | 1,207 | 1,222 | 1,201.2 | 1,211 | 33,55,097 | 59.81 |
| 2026-09-21 | 1,185 | 1,211.9 | 1,185 | 1,198.3 | 17,18,834 | 55.73 |
| 2026-09-18 | 1,182.6 | 1,207.5 | 1,182.1 | 1,185 | 30,02,566 | 58.06 |

## Corporate actions

| Ex-date | Type | Detail |
| --- | --- | --- |
| 2024-10-28 | SUBDIVISION | Face Value Split (Sub-Division) - From Rs 5/- Per Share To Re 1/- Per Share |

## More data

- JSON with one year of daily history: https://bhavcopy.live/agents/stocks/DRREDDY.json
- Full history (compact app format, see /llms.txt): https://bhavcopy.live/market_data/equity-details/DRREDDY.json
- Market overview: https://bhavcopy.live/agents/market.md

_For information only. Not investment advice. Verify with the exchange before acting on this data._